Effects of the Prodrug Nabumetone, and its Active Metabolite, 6-MNA, on Human and Rat Gastric Mucosal Prostanoids and Platelet Function
- 1 January 1990
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 40 (Supplement), 53-56
- https://doi.org/10.2165/00003495-199000405-00013
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALThe Lancet, 1988
- Platelet thromboxane A2 synthesizing capacity is enhanced by fasting but diminished by diabetes mellitus in the rat.1988
- Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response.1987
- Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetoneAmerican Journal Of Medicine, 1987
- Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1α production and on bile salt-induced changes in gastric mucosal functionJournal of Pharmacy and Pharmacology, 1987
- Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.Gut, 1987
- Differential regional changes of prostacyclin and thromboxane A2 synthesis in the intestinal tract of the fasted and semistarved ratPflügers Archiv - European Journal of Physiology, 1987
- Metabolism of nabumetone (BRL 14777) by various species including manXenobiotica, 1984
- Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.BMJ, 1983
- Cytoprotection of the gastrointestinal mucosa.1983